The Latest in B Cell Lymphoma

Can reversing T-cell exhaustion benefit in B-cell lymphoma relapse?

September 15, 2021

B Cell Lymphoma

FDA approves zanubrutinib in Waldenström’s macroglobulinemia

September 7, 2021

B Cell Lymphoma

Hematologic cancer increases risk of delivery complications

July 22, 2021

B Cell Lymphoma

Real-world CAR T outcomes for DLBCL mimic clinical trials

June 28, 2021

Experimental antibody-drug conjugate shown active against r/r DLBCL

June 15, 2021

Choosing the right R-CHOP dosage for elderly patients with DLBCL

June 8, 2021

High-dose methotrexate of no CNS benefit for patients with high-risk DLBCL

May 18, 2021

Pediatric cancer survivors at risk for opioid misuse

May 5, 2021

No SPARKLE with ibrutinib plus chemo in r/r pediatric B-NHL

May 5, 2021

B Cell Lymphoma

FDA approves loncastuximab for diffuse large B-cell lymphomas

April 27, 2021

B Cell Lymphoma

Evidence favors lower-dose R-CHOP for fit, very elderly DLBCL patients

April 14, 2021

Poor survival with COVID in patients who have had HSCT

March 26, 2021

Omidubicel improves on umbilical cord blood transplants

March 22, 2021

B Cell Lymphoma

High-dose chemo no better than standard dose for B-cell lymphoma

March 17, 2021

B Cell Lymphoma

Don’t delay: Cancer patients need both doses of COVID vaccine

March 15, 2021